<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p48" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_48{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_48{left:341px;bottom:30px;}
#t3_48{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_48{left:377px;bottom:30px;}
#t5_48{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_48{left:540px;bottom:30px;}
#t7_48{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_48{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_48{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_48{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_48{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_48{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_48{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_48{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_48{left:1109px;bottom:47px;letter-spacing:0.18px;}
#tg_48{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_48{left:438px;bottom:778px;letter-spacing:0.39px;word-spacing:-0.22px;}
#ti_48{left:764px;bottom:786px;}
#tj_48{left:35px;bottom:282px;}
#tk_48{left:45px;bottom:276px;letter-spacing:0.08px;word-spacing:-0.01px;}
#tl_48{left:376px;bottom:276px;letter-spacing:0.12px;}
#tm_48{left:406px;bottom:276px;letter-spacing:0.13px;}
#tn_48{left:480px;bottom:276px;}
#to_48{left:35px;bottom:266px;}
#tp_48{left:45px;bottom:260px;letter-spacing:0.12px;word-spacing:0.01px;}
#tq_48{left:35px;bottom:249px;}
#tr_48{left:45px;bottom:243px;letter-spacing:0.12px;word-spacing:-0.03px;}
#ts_48{left:555px;bottom:243px;}
#tt_48{left:35px;bottom:232px;}
#tu_48{left:45px;bottom:226px;letter-spacing:0.12px;word-spacing:0.01px;}
#tv_48{left:44px;bottom:209px;letter-spacing:0.14px;}
#tw_48{left:35px;bottom:198px;}
#tx_48{left:45px;bottom:192px;letter-spacing:0.11px;word-spacing:-0.04px;}
#ty_48{left:44px;bottom:176px;letter-spacing:0.14px;}
#tz_48{left:35px;bottom:165px;}
#t10_48{left:45px;bottom:159px;letter-spacing:0.1px;word-spacing:-0.02px;}
#t11_48{left:44px;bottom:142px;letter-spacing:0.12px;word-spacing:0.01px;}
#t12_48{left:35px;bottom:131px;letter-spacing:0.08px;}
#t13_48{left:52px;bottom:125px;letter-spacing:0.11px;}
#t14_48{left:44px;bottom:108px;letter-spacing:0.11px;word-spacing:0.01px;}
#t15_48{left:36px;bottom:748px;letter-spacing:-0.24px;}
#t16_48{left:36px;bottom:729px;letter-spacing:-0.1px;}
#t17_48{left:351px;bottom:737px;letter-spacing:-0.12px;}
#t18_48{left:36px;bottom:711px;}
#t19_48{left:47px;bottom:711px;letter-spacing:-0.09px;}
#t1a_48{left:36px;bottom:693px;letter-spacing:-0.1px;}
#t1b_48{left:41px;bottom:674px;}
#t1c_48{left:58px;bottom:674px;letter-spacing:-0.09px;word-spacing:-0.05px;}
#t1d_48{left:721px;bottom:674px;letter-spacing:-0.3px;}
#t1e_48{left:781px;bottom:674px;letter-spacing:-0.04px;}
#t1f_48{left:63px;bottom:656px;}
#t1g_48{left:76px;bottom:656px;letter-spacing:-0.09px;}
#t1h_48{left:41px;bottom:638px;}
#t1i_48{left:58px;bottom:638px;letter-spacing:-0.09px;}
#t1j_48{left:63px;bottom:619px;}
#t1k_48{left:76px;bottom:619px;letter-spacing:-0.09px;}
#t1l_48{left:547px;bottom:627px;}
#t1m_48{left:36px;bottom:546px;letter-spacing:-0.1px;}
#t1n_48{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_48{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_48{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_48{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_48{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_48{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_48{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_48{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_48{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s8_48{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_48{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sa_48{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sb_48{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_48{font-size:17px;font-family:Webdings_k6;color:#000;}
.sd_48{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.se_48{font-size:17px;font-family:SymbolMT_ka;color:#000;}
.sf_48{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts48" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: SymbolMT_ka;
	src: url("fonts/SymbolMT_ka.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg48Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg48" style="-webkit-user-select: none;"><object width="1210" height="935" data="48/48.svg" type="image/svg+xml" id="pdf48" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_48" class="t s0_48">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_48" class="t s1_48">® </span>
<span id="t3_48" class="t s0_48">(NCCN </span>
<span id="t4_48" class="t s1_48">® </span>
<span id="t5_48" class="t s0_48">), All rights reserved. NCCN Guidelines </span>
<span id="t6_48" class="t s1_48">® </span>
<span id="t7_48" class="t s0_48">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_48" class="t s2_48">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_48" class="t s2_48">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_48" class="t s3_48">NCCN Guidelines Version 4.2024 </span>
<span id="tb_48" class="t s3_48">Cancer of the Glottic Larynx </span>
<span id="tc_48" class="t s4_48">NCCN Guidelines Index </span>
<span id="td_48" class="t s4_48">Table of Contents </span>
<span id="te_48" class="t s4_48">Discussion </span>
<span id="tf_48" class="t s5_48">GLOT-A </span>
<span id="tg_48" class="t s5_48">2 OF 2 </span>
<span id="th_48" class="t s5_48">PRINCIPLES OF RADIATION THERAPY </span>
<span id="ti_48" class="t s6_48">1 </span>
<span id="tj_48" class="t s7_48">1 </span>
<span id="tk_48" class="t s8_48">See Principles of Radiation Techniques (RAD-A) </span><span id="tl_48" class="t s9_48">and </span><span id="tm_48" class="t s8_48">Discussion</span><span id="tn_48" class="t s9_48">. </span>
<span id="to_48" class="t s7_48">4 </span>
<span id="tp_48" class="t s9_48">Suggest 44–50 Gy in 3D-CRT and sequentially planned IMRT or 54–63 Gy with IMRT dose painting technique (dependent on dose per fraction). </span>
<span id="tq_48" class="t s7_48">5 </span>
<span id="tr_48" class="t s8_48">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="ts_48" class="t s9_48">. </span>
<span id="tt_48" class="t s7_48">7 </span>
<span id="tu_48" class="t sa_48">Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med </span>
<span id="tv_48" class="t s9_48">2004;350:1945-1952. </span>
<span id="tw_48" class="t s7_48">8 </span>
<span id="tx_48" class="t s9_48">Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. </span>
<span id="ty_48" class="t s9_48">N Engl J Med 2004;350:1937-1944. </span>
<span id="tz_48" class="t s7_48">9 </span>
<span id="t10_48" class="t s9_48">Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus </span>
<span id="t11_48" class="t s9_48">chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27:843-850. </span>
<span id="t12_48" class="t s7_48">10 </span>
<span id="t13_48" class="t s9_48">Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy </span>
<span id="t14_48" class="t s9_48">in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;84:1198-1205. </span>
<span id="t15_48" class="t s5_48">POSTOPERATIVE: </span>
<span id="t16_48" class="t s5_48">RT or Concurrent Systemic Therapy/RT </span>
<span id="t17_48" class="t s6_48">5,7-10 </span>
<span id="t18_48" class="t s5_48">• </span><span id="t19_48" class="t sb_48">Preferred interval between resection and postoperative RT is ≤6 weeks. </span>
<span id="t1a_48" class="t s5_48">• PTV </span>
<span id="t1b_48" class="t sc_48"></span><span id="t1c_48" class="t s5_48">High risk: Adverse pathologic features such as positive margins (see footnote l on </span><span id="t1d_48" class="t sd_48">GLOT-3</span><span id="t1e_48" class="t s5_48">). </span>
<span id="t1f_48" class="t se_48">◊ </span><span id="t1g_48" class="t s5_48">60–66 Gy (2.0 Gy/fraction); daily Monday–Friday in 6–6.5 weeks </span>
<span id="t1h_48" class="t sc_48"></span><span id="t1i_48" class="t s5_48">Low to intermediate risk: Sites of suspected subclinical spread </span>
<span id="t1j_48" class="t se_48">◊ </span><span id="t1k_48" class="t s5_48">44–50 Gy (2.0 Gy/fraction) to 54–63 Gy (1.6–1.8 Gy/fraction) </span>
<span id="t1l_48" class="t s6_48">4 </span>
<span id="t1m_48" class="t s5_48">Either IMRT (preferred) or 3D-CRT is recommended. </span>
<span id="t1n_48" class="t sf_48">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
